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Ethnic Differences in Cancer Incidence:
A Markerfor Inherited Susceptibility?
Frank D. Gilliland
Department of Internal Medicine and Epidemiology, University
of New Mexico School of Medicine,Albuquerque, New Mexico
Cancer incidence varies markedly by ethnicity and geographic location. Ethnic variation in cancer
occurrence has traditionally been ascribed to differences in social, cultural, economic, and
physical environments. However, this interpretation of the epidemiologic evidence may need to
be revised as a result of new biological evidence and theories of carcinogenesis. Carcinogenesis
is now recognized to be a multistep process during which mutations or heritable changes in
expression occur in genes involved in cellular growth control and genome stability. Inherited
cancer susceptibility may be a stronger determinant of ethnic differences in cancer incidence
than is currently appreciated. To examine the potential role of inherited susceptibility, the
theoretical contribution of inherited susceptibility to ethnic differences in rates is considered using
a simple probability model. Germline mutations in tumor suppressor genes BRCA1 and p53 are
used to illustrate the magnitude of the ethnic differences for breast cancer that might arise from
differences in inherited susceptibility. Our simple model suggests that ethnic differences in
cancer occurrence can result from differences in genetic susceptibility. However, the magnitude
of ethnic relative risk is likely to more strongly reflect differences in the distribution of
susceptibility genotypes between groups than the magnitude of the disease risk associated with
the genotypes. For many scenarios, the ethnic relative risk arising from differences in
susceptibility may be bounded by the ratio of the proportion of susceptible individuals in each
group. Environ Health Perspect 105(Suppl 4):897-900 (1997)
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Introduction
It has long been recognized that cancer
rates show enormous variation by ethnic-
ity and geographic location (1-4). For
example, rates for melanoma in whites liv-
ing in Queensland, Australia, are 155-fold
higher than rates for Japanese residents of
northern Japan (Table 1). Blacks in the
United States have a 70-fold higher inci-
dence rate for prostate cancer compared
with rates for several Asian groups. Large
variations of cancer rates by ethnic group
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are still apparent when restricted to one
geographic location, the United States
(Table 2, 3), where blacks have the high-
est rate for all sites combined and Native
Americans have the lowest rate. The varia-
tion in the United States is even greater
for specific types of cancer, with some
types having a 10-fold difference between
ethnic groups. Rates for esophageal
cancer, for example, vary from 18.9 for
blacks to 1.9 for Native Americans.
American females show a similar varia-
tion by ethnic group. The data indicate
that the large differences in cancer rates





Apparent ethnic variation in cancer
incidence may arise from information bias
and confounding as well as from true dif-
ferences in cancer occurrence. The expla-
nations for ethnic differences in cancer rates
fall into four categories, which are based
in part on lists presented in Polendak (5)
and MacMahon and Pugh (6). The cate-
gories are as follows:
Measurement errors:
* Inadequate data-insufficient informa-
tion, based upon clinical impressions,
etc
* Differential access to medical care and
diagnostic facilities
* Differences in reporting due to cultural
factors or to difference in the severity of
disease; differential use of available
facilities
* Differing fashions ofdiagnosis.
* Coding death certification
Differences between groups with respect
to more directly associated demographic
variables:
* Differences in socioeconomic class and
occupation, and secondary factors asso-
ciated with these differences (see
Differences in environment, below)
Differences in environment:
* Climatic differences and their effects
* Geographic variation in disease fre-
quency
* Nutrition or diet
* Differences in personal customs or
habits (e.g., reproductive and nursing
habits; use oftobacco and alcohol, and
differences in sexual practices)
* Differences with respect to social and
family structure relationships, role
behavior
* Cultural factors
* Differences related to rates ofgrowth
and development
Genetic differences:
* HIA dass II alleles
* HLA-haplotypes
* Metabolic enzyme polymorphisms
* ABO blood groups
Valid comparison of rates depends
upon accurate diagnosis and reporting of
cancer cases. Bias from measurement errors
can result from differences in access to
medical care and utilization ofcare and to
differences in diagnosis and death certifi-
cate reporting, all of which probably
account for a portion ofthe ethnic varia-
tion in cancer rates (2). The bias from
measurement error is likely to be substan-
tial and may also explain some ofthe inter-
national variation in cancer mortality rates.
However, international standardization of
registration procedures has resulted in
improved data on cancer incidence world-
wide (2), and it is doubtful that informa-
tion bias explains much of the ethnic
variation in rates calculated from data
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Table 1. International ethnic variation in cancer incidence. collected by the Surveillance, Epidemiology,
Ratio, and End Results Program (SEER) in the
Type of cancer high/low High incidence area Low incidence area United States.
There are marked differences in the
Melanoma 155 Australia (Queensland) Japan(Osaka)UntdSaeadwol ieinhetnc Lip 151 Canada (Newfoundland) Japan (Osaka)UntdSaeadwol ieinhe tnc
Nasopharynx 100 Hong Kong United States (Southwest) distribution of age, socioeconomic status
Prostate 70 United States (Atlanta, black) China (Tianjin) (SES), and occupation (3,7-11). Because
Liver 49 China (Shanghai) Canada (Nova Scotia) these factors are strong determinants of
Penis 42 Brazil (Recife) Israel (Born in Europe, America)
cne ik ifrne nterdsrbto Oral cavity 34 France (Bas-Rhin) India (Poona) cne ik ifrne nterdsrbto
Cervix uteri(femalIe) 28 Brazil (Recife) Israel (non-Jews) among ethnic groups could explain a por-
Esophagus 27 France (Calvados) Romania (urban Cluj) tion of the ethnic variation in cancer rates.
Stomach 22 Japan (Nagasaki) Kuwait(Kuwaitis) H wvr aito naei cone o Thyroid 22 Hawaii (Chinese) Poland (Warsaw City) Hwvr aito naei cone o
Multiple myeloma 22 United States (Alameda, CA, black) Philippines (rural) in the data by age adjustment and does not
Kidney 21 Canada (NorthwestTerritory, Yukon) India (Poona) cnrbt oehi ifrne nrts Corpus uteri(femalIe) 21 United States (San Francisco Bay area, white) India (Nagpur) conteribteto rethicwdifterne lineratueis; Lung 19 United States (New Orleans, black) India (Madras) wieciia eiwo h ieauei
Colon 19 United States (CT, white) India (Madras) beyond the scope of this discussion, SES
Testis 17 Switzerland (urban Vaud) China (Tianjin) and occupation do not appear to fully Bladder 16 Switzerland (Basel) India (Nagpur) explain the ethnic variation in cancer risk
Lymphosarcoma 12 Switzerland (Basel) Japan (rural Miyagi)fomstcnesis(3791)
Pancreas 11 United States (Los Angeles, Korean) India(Poona)fomstcnesis 3791)
Hodgkin'sdisease 10 Canada(Quebec) Japan(Miyagi) Environmental factors, including
Brain 9 New Zealand (Polynesian Islanders) India (Nagpur) lifestyle and dietary factors; have tradition-
Larynx B Brazil (So Paulo) Japan (rural Miyagi) al entogtt etemi oriu
Ovary(female) B NewZealand (Polynesian Islanders) Kuwait(Kuwaitis) al entogtt etemi otiu
Rectum B Israel (Born in Europe, America) Kuwait(Kuwaitis) tors to ethnic differences in cancer rates
Breast(female) 7 Hawaii (Hawaiian) Israel (non-Jews) (3,9,11). In a now classic analysis, Doll
Leukemia 5 Canada (Ontario) India (Nagpur) and Peto (11) examined international dif-
Data from Fraumeni et al. (1), adapted from Parkin et al. (2). ferences in cancer rates and concluded that
80% of cancers had environmental causes.
Table 2. United States variation in cancer incidence for males by site: average annual age-adjusted incidence However, new biological evidence and the-
rates in males. onies of carcinogenesis suggest this inter-
Native pretation ofethnic variation in cancer rates
Type of cancer White Black Hispanic American Chinese Japanese Filipino Hawaiian may need to be revised.
All sites 404.1 490.2 265.5 184.5 292.7 303.6 242.0 39B.9 Carcinogenesis is now recognized to be
Esophagus 4.9 18.4 2.9 1.9 6.1 5.6 4.9 15.1 a multistep process with crucial steps
Stomach 11.5 20.5 20.8 26.1 14.5 3B.6 9.6 40.4 involving mutations or heritable changes in
Colon 40.3 40.7 17.9 B.4 33.6 42.1 24.0 25.B xrsino e eesivle nclua Rectum 20.0 14.9 11.5 5.0 19.3 23.4 16.9 18.7 exressi ontrof key geneinolved saincllula Liver 2.7 5.2 4.5 19.5 7.1 10.2 9.B 2.7 grwhcnoladg om stbiy
Gall bladder O.B 0.8 1.5 B.9 1.2 1.5 1.2 1.4 (12-14). Cancer risk is determined by the
Lung/bronchus 82.1 119.6 32.2 14.2 60.2 4B.4 39.9 108.2 prb iltofm ainsnkegns 1) Skin melanoma 9.B 0.B 1.6 2.2 0.4 1.5 1.2 1.6 probabilit mofelmuaionsiv ind key genetsus(13). Prostate 77.3 122.8 71.5 45.5 32.5 45.7 47.4 59.6 Intimoe,ndvuagntcsucp-
Testis 4.2 0.8 3.0 1.8 1.9 1.3 0.5 2.6 bility can arise by two pathways; first, from
Bladder 30.2 15.1 10.9 3.6 13.9 12.5 6.0 10.6 mutations in key genes on the pathway to
Brain/nervous system 7.3 4.3 4.9 3.1 3.0 3.1 3.4 3.1
cne,sc socgnsadtmrsp
Based on data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer pressor genes; and second, from genotypes
Institute, adapted from Parker et al. (2). that increase the probability of mutations
in key genes in conjunction with specific
Table 3. United States variation in cancer incidence for females by site: average annual age-adjusted incidence environmental exposures.
rates in females. The role ofgenetic susceptibility as an
Native explanation for ethnic variation in cancer
Type of cancer White Black Hispanic American Chinese Japanese Filipino Hawaiian risk has not been extensively studied.
All sites 316.1 296.6 220.4 168.8 242.2 214.0 202.6 344.1 Overall measures ofgenetic differences in
Esophagus 1.6 5.0 0.8 0.3 1.2 0.8 1.9 2.2 populations indicate that genetic variation
Stomach 5.1 8.5 10.0 12.3 8.7 19.0 7.2 17.9 is as least as great within ethnic groups as
Colon 32.3 35.0 16.7 8.1 23.7 25.7 14.9 16.3 between groups. However, ethnic
Rectum 12.8 10.8 7.6 3.2 10.9 10.9 8.1 8.1
Liver 1.1 1.7 1.9 2.6 4.7 2.4 3.2 2.7 variation in the distribution ofspecific sus-
Gall bladder 0.6 1.1 7.1 17.1 1.0 1.7 1.8 1.3 ceptibility genotypes does occur. The dis-
Lung/bronchus 29.7 31.2 15.6 4.6 27.6 13.2 17.9 45.8 tribution of a number of mutations in
Skin melanoma 8.2 0.7 2.2 0.7 0.7 1.0 0.9 1.0
tmrsprso ee n eaoi Breast 91.5 76.4 50.9 25.6 58.7 57.1 45.6 104.6 tm rsprso ee n eaoi
Cervix uteri 8.8 19.7 17.1 20.0 10.5 5.8 10.8 14.5 polymorphisms has been reported to vary
Bladder 7.7 5.5 3.3 0.4 4.0 4.4 3.1 6.0 by ethnic group (15-17).
Brain/nervous system 5.1 2.9 2.4 1.8 2.7 2.2 1.3 4.2 Incidence rates for breast cancer show
Based on data from the SEER Program, adapted from Parker et al. (2). marked contrasts amonfg ethnic groups
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(16,18-20). Mutations in the BRC41 gene
are associated with increased risk for breast
and ovarian cancer. This gene is composed
of 5592 nucleotides spread over 100,000
bases ofgenomic DNA. It contains 22 cod-
ing exons that produce an 1863 amino acid
protein, which shows no homology to any
known protein except for a RING finger
motifnear the N-terminus. It is thought to
act as a tumor suppressor gene (21).
Carriers of BRCA1 mutations are
heterozygotes and have been shown to have
a greater than 85% lifetime risk ofdevelop-
ing breast cancer and 45% risk ofovarian
cancer compared to a 12% risk for women
in the general popualtion (22,23). The risk
of breast cancer for carriers of BRCAI
mutations varies by age; women 50 years of
age have a 50% risk for breast cancer. The
frequency of BRCA1 mutations within a
population varies between ethnic groups,
from 1 in > 1000 for Japanese to 1 in 100
for Ashkenazi Jews (16,19,24). Studies
have also indicated that some mutations
are specific for a given ethnic group, such
as the 185 de/AG mutation found in the
Ashkenazis (25). Differences in genotype
distribution may result from differences in
consanguinity, mutation rate, natural selec-
tion, and random effects such as founder
effects and isolation (4).
To consider the potential contribution
ofgenetic susceptibility to ethnic variation
in cancer incidence, we used simple proba-
bility models to estimate the magnitude of
cancer risk differences that might stem
from ethnic differences in genetic suscepti-
bility arising from one ofthe two pathways
to increased risk and inheritance of muta-
tions in a tumor suppressor gene. We
assumed the simple case where risk is
independent ofexposure.
Methods
For populations, genetic susceptibility is
defined as the proportion of the popula-
tion with either germline mutations of
key genes, such as oncogenes or tumor
suppressor genes, or with susceptibility
genotypes. The proportion with suscepti-
bility genotypes depends on the fre-
quency of susceptibility alleles and the
functional relationship between alleles.
Consider a simple model for genetic sus-
ceptibility in an ethnic population:
Genetic susceptibility arises from one
gene with two alleles, with one allele, N,
for nonsusceptibility and the second
allele, S, for susceptibility. The alleles fol-
low Mendelian inheritance in either a
dominant or recessive pattern.
The proportion ofthe population with
susceptibility genotypes depends upon
whether the susceptible allele, S, is domi-
nant or recessive. Ifit is dominant, as with
tumor suppressor genes, both SS and NS
genotypes will be susceptible and the pro-
portion of susceptibles in the population
will be given by q(2-q), where q is the
susceptible allele frequency. For the case
where the susceptibility allele is recessive,
only the SS genotype will be susceptible
and the proportion of susceptibles in the
population will be given by q2. For a sus-
ceptibility allele frequency of 10%, a domi-
nant susceptibility allele will result in 19%
being susceptible. Under a recessive model,
only 1% of the population is susceptible.
In the following models, the susceptible
proportion will be used as the parameter
for population genetic susceptibility.
In a comparison of rates in two ethnic
groups, where RRe= ethnic relative risk,
Ra=the disease risk in ethnic group A, and
Rb=the disease risk in ethnic group B
RRe = R.
Rb
is an accepted measure ofethnic variation
in cancer risk.
In the simple case in which cancer risk
is determined by inheritance ofa mutation
in a single tumor suppressor gene and eth-
nic differences in risk arise from differ-
ences in the allele distribution ofthis gene,
the ethnic relative risk can be expressed as
a ratio of disease risk between the two
ethnic groups:
RRe -1 P,(Rg -1) +1
P1(Rg-1)+1
where Pa and Pb are the proportions of
susceptibles in groups A and B, respec-
tively, and Rg is the risk ratio for those
with the susceptible genotype compared
with those with the nonsusceptible geno-
type. Assumptions for this model are that
baseline risks are equal in the two ethnic
groups, and Rg is constant and indepen-
dent ofexposure or mutation spectrum.
Figures 1 and 2 illustrate the general
form of the relationship among RRe, Rg,
and the distribution of the proportion of
susceptibles. For specific examples, we
chose to examine the ethnic relative risk
that could arise from differences in the
proportion with cancer susceptibility aris-
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Figure 1. Relative risk comparing any two ethnic







1.l3 ,' ..... ......
12-
1 100 200 300 400 500 600 700 800 900 1O0
Relative riskfor susceptibility genotypes
---Pa =0.01, Pb =0.005 Pa =0.0001, Pb=0.00005
Pa
=0.001, Pb
= 0.0005 Pa = 0000001, Pb =0.000005
Figure 2. Relative risk comparing any two ethnic
groups with differing proportions of susceptibility
genotypes.
ferent characteristics, p53and BRCAI. The
germline mutation frequency for p53 is
low, approximately i0-5, but the cancer
relative risk is high, in the 104 to 105 range
(26). For BRCAJ, the frequency is approx-
imately 5 per 1000, but it has been found
to show ethnic variation (16,17,25). The
relative risk associated with BRCAI varies
with age and is approximately 200 in
women aged less than 45 years.
Results and Discussion
Figure 1 shows the general relationship
between the ethnic relative risk (RRe),
shown on theyaxis, the relative risk for sus-
ceptibility genotypes, Rg, shown on the x
axis, and two pairs ofvalues for the suscepti-
ble proportions in two ethnic groups,
denoted by Pa and Pb. The maximum value
ofthe RRewill not exceed the ratio ofsus-
ceptible proportions in the two groups,
Pa/Pb. For example, ifthe proportion sus-
ceptible in ethnic group A is twice that in
ethnic group B, the maximum RReis 2. The
maximum ethnic relative risk reflects the
ratio ofPa and P1, not the magnitude ofRg,
the relative riskforsusceptibility genotypes.
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The rate atwhich the ethnic relative risk
approaches its maximum value as Rg
increases depends upon the magnitude of
the proportion of susceptibles in the
groups. To see this more concretely, con-
sider two scenarios, both with a P4/Pb ratio
of5, as shown in Figure 1. First, in thehigh
Pascenario halfofgroup A is susceptible, so
Pa=0.5 and one-tenth ofgroup Bis suscep-
tible, so Pb=0.1, giving a Pa,Pb ratio of 5.
Second, the low Pa scenario, where
P4,=0.05 and Pb=0.01, again a PalPb ratio
of 5. As the relative risk for susceptibility
genotypes increases, the ethnic relative risk
increases to its maximum faster for the high
Pa than for the low Pa scenario. Thus for a
given susceptibility genotype, relative risk
and Pa,Pb ratio, the higher the proportion
of susceptibles, the higher the ethnic
relative risk.
In consideration ofplausible values of
P4 and Pb and relative risks forsusceptibil-
ity genotypes, Figure 2 shows the ethnic
relative risk on the y axis and the relative
risk for susceptibility genotype on the x
axis. The ranges of the relative risks for
the genotype and the groups proportion
of susceptibles were chosen for plausible
values for tumor suppressor genes p53
and BRCAL.
Figure 2 shows a comparison of two
ethnic groups with differing BRCA1 muta-
tion frequencies, with RRefor a susceptible
proportion of 1 in 100 versus 5 in 1000.
The ethnic relative risk increases rapidly to
1.5 for a susceptibility genotype relative
risk of200. These values ofthe susceptibil-
ity proportion and genotype relative risks
are in the ballpark for BRCAI in young
women from specific ethnic groups
(16,17,25). Differences in BRCAI fre-
quency could explain ethnic relative risks
for breast cancer in the 1.5 to 2 range for
youngwomen.
For a population with lower suscep-
tibility proportions, such as that observed
for germlinep53 mutations, the ethnic rel-
ative risk is small for plausible relative risks
for susceptible genotypes. These values are
in the range observed for several tumor
suppressor genes, indicating that these
genes are unlikely to explain even small
ethnic differences.
In summary, ethnic differences in
cancer occurrence may be a marker ofdif-
ferences in genetic susceptibility. For breast
cancer, observed differences in the fre-
quency ofBRCA1 mutations could account
for ethnic differences in rates for young
women. However, the magnitude ofethnic
relative risk is likely to more strongly
reflect differences in the distribution ofsus-
ceptibility genotypes between groups than
the magnitude ofthe disease risk associated
with the genotypes. For many scenarios,
the ethnic relative risk arising from differ-
ences in susceptibility may be bounded by
the ratio ofthe proportion ofsusceptible
individuals in each group.
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